Omada Health (NASDAQ:OMDA) CEO Sells $327,175.20 in Stock

Key Points

• CEO Sean Duffy sold 14,960 Omada Health shares at an average price of $21.87, generating $327,175.20 and reducing his direct stake by 3.76% to 382,594 shares.
• Omada Health shares rose 4.3% to $20.50, while the company’s latest quarterly results exceeded expectations with EPS of $0.08 versus the $0.02 loss analysts expected and revenue of $87.83 million.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $26.67; institutional investors including BlackRock also recently established sizable positions.

Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) CEO Sean Duffy sold 14,960 shares of Omada Health stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $21.87, for a total value of $327,175.20. Following the completion of the sale, the chief executive officer directly owned 382,594 shares of the company's stock, valued at $8,367,330.78. The trade was a 3.76% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Omada Health Trading Up 4.3%

OMDA stock traded up $0.84 during trading on Monday, reaching $20.50. The stock had a trading volume of 961,447 shares, compared to its average volume of 1,250,359. The firm has a market cap of $1.26 billion, a PE ratio of 410.00 and a beta of 1.86. The stock's 50 day moving average is $22.63 and its two-hundred day moving average is $17.97. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92.

Omada Health (NASDAQ:OMDA - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.02) by $0.10. Omada Health had a return on equity of 2.60% and a net margin of 1.39%.The business had revenue of $87.83 million during the quarter, compared to the consensus estimate of $80.93 million. On average, research analysts anticipate that Omada Health, Inc. will post 0.09 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on OMDA shares. BTIG Research reiterated a "buy" rating and set a $35.00 price target on shares of Omada Health in a research note on Friday. Robert W. Baird upped their price objective on Omada Health from $15.00 to $25.00 and gave the stock a "neutral" rating in a research note on Wednesday, August 12th. Wall Street Zen upgraded Omada Health from a "hold" rating to a "buy" rating in a research report on Saturday, August 8th. BMO Capital Markets reissued an "outperform" rating and set a $24.00 price target on shares of Omada Health in a report on Friday, August 7th. Finally, Morgan Stanley restated an "overweight" rating and issued a $30.00 price target on shares of Omada Health in a research report on Monday, June 22nd. Eleven equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $26.67.

Institutional Trading of Omada Health

A number of hedge funds and other institutional investors have recently modified their holdings of the company. BlackRock Inc. purchased a new position in shares of Omada Health during the 2nd quarter valued at $48,775,000. Jefferies Financial Group Inc. bought a new stake in Omada Health during the fourth quarter valued at about $16,948,000. BIT Capital GmbH lifted its position in shares of Omada Health by 52.4% in the fourth quarter. BIT Capital GmbH now owns 940,238 shares of the company's stock valued at $14,837,000 after acquiring an additional 323,365 shares in the last quarter. Madryn Asset Management LP purchased a new position in shares of Omada Health in the second quarter valued at about $12,814,410. Finally, Walleye Capital LLC bought a new position in shares of Omada Health in the second quarter worth about $11,648,000.

Omada Health Company Profile

Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines clinical care, health coaching, connected devices, digital tools and personalized support to help members improve health outcomes and manage conditions over time.

The company's offerings address areas including diabetes, hypertension, weight health and musculoskeletal conditions. Omada's programs are designed to support prevention and ongoing care through services such as remote monitoring, personalized health guidance, educational content and access to healthcare professionals.

Omada primarily serves members through employers, health plans and healthcare organizations in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.